Search

everythinglearnresearchcommunity

for

Search:↓

A teenage girl's excessive hair growth was caused by a medication for mania, but improved after stopping the medication.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Some people experience severe, long-lasting side effects from fluoroquinolone antibiotics, leading to the recommendation of limited use and increased awareness of these risks.

miR-22, a type of microRNA, controls hair growth and its overproduction can cause hair loss, while its absence can speed up hair growth.

Wnt10b overexpression can regenerate hair follicles, possibly helping treat hair loss and alopecia.

Flightless I protein affects hair growth, with low levels delaying it and high levels increasing hair length in rodents.

Hair follicle dermal stem cells are key for regenerating parts of the hair follicle and determining hair type.

The LncRNA AC010789.1 slows down hair loss by promoting hair follicle growth and interacting with miR-21 and the Wnt/β-catenin pathway.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Mice lacking fibromodulin have disrupted healing patterns, leading to abnormal skin repair and scarring.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

The document concludes that managing PCOS requires a comprehensive approach, including lifestyle changes and medication, to improve symptoms and reduce health risks.

Thymic stromal lymphopoietin (TSLP) promotes hair growth, especially after skin injury.

Hair loss can be treated with medications like minoxidil and finasteride or surgery, but treatment effectiveness varies by alopecia type and accurate diagnosis is important.

Stem cell therapies could be a promising alternative for hair loss treatment, but more research is needed to understand their full potential and safety.

Minoxidil can cause a skin reaction called ALEP.

CXCL12 protein slows down hair growth through its receptor CXCR4. Blocking this can potentially increase hair growth.

DNA methylation is essential for skin and hair follicle development, and could be a target for treating skin diseases.

The TGF-β family helps control how cells change and move, affecting skin, hair, and organ development.

The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.

The document concludes that early recognition and appropriate treatment of red scalp, red ear, and red scrotum syndromes can lead to remission.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

COVID-19 patients may experience hair loss, but it's not linked to their age or sex.

COVID-19-related hair loss may have unique features compared to hair loss from other causes.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

Vitamin B3 may help prevent hair loss and promote hair growth by protecting scalp cells from stress and reducing hair growth-blocking proteins.

Higher levels of ischemia-modified albumin in telogen effluvium patients may indicate oxidative stress.

Rivaroxaban can cause liver injury, allergic reactions, blood vessel inflammation, and hair loss, but these side effects are rare.